Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing.

Aerosols Air Microbiology COVID-19 / prevention & control Cough Disease Transmission, Infectious Humans Pandemics / prevention & control Risk Assessment / methods SARS-CoV-2 Singing Sneezing

Journal

Environmental health perspectives
ISSN: 1552-9924
Titre abrégé: Environ Health Perspect
Pays: United States
ID NLM: 0330411

Informations de publication

Date de publication:
04 2021
Historique:
entrez: 1 4 2021
pubmed: 2 4 2021
medline: 10 4 2021
Statut: ppublish

Résumé

Evidence for indoor airborne transmission of SARS-CoV-2 is accumulating. We assessed of the risk of illness due to airborne SARS-CoV-2 particles from breathing, speaking, singing, coughing, and sneezing in indoor environments. A risk assessment model, The expelled volume of aerosols was highest for a sneeze, followed by a cough, singing, speaking, and breathing. After 20 min of exposure, at The large variation in the volume of expelled aerosols is discussed. The model calculations indicated that SARS-CoV-2 transmission via aerosols outside of the

Sections du résumé

BACKGROUND
Evidence for indoor airborne transmission of SARS-CoV-2 is accumulating.
OBJECTIVES
We assessed of the risk of illness due to airborne SARS-CoV-2 particles from breathing, speaking, singing, coughing, and sneezing in indoor environments.
METHODS
A risk assessment model,
RESULTS
The expelled volume of aerosols was highest for a sneeze, followed by a cough, singing, speaking, and breathing. After 20 min of exposure, at
DISCUSSION
The large variation in the volume of expelled aerosols is discussed. The model calculations indicated that SARS-CoV-2 transmission via aerosols outside of the

Identifiants

DOI: 10.1289/EHP7886 PMID: 33793301 PMC: PMC8016178
pubmed: 33793301
doi: 10.1289/EHP7886
pmc: PMC8016178
doi:

Substances chimiques

Aerosols 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

47002

Commentaires et corrections

Type : ErratumIn

Références

Aerosol Sci Technol. 2020 Apr 03;0(0):1-4
pubmed: 32308568
Sci Total Environ. 2020 Aug 20;731:139178
pubmed: 32388162
Wellcome Open Res. 2020 Apr 9;5:67
pubmed: 32685698
J Infect Dis. 2020 Jul 23;222(4):564-571
pubmed: 32525979
Med Hypotheses. 2020 Aug;141:109781
pubmed: 32361528
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Virol J. 2013 Jun 22;10:204
pubmed: 23800032
Sci Transl Med. 2020 Dec 9;12(573):
pubmed: 33229462
Risk Anal. 2019 Dec;39(12):2608-2624
pubmed: 31524301
Indoor Air. 2017 Jan;27(1):179-190
pubmed: 26945674
Emerg Infect Dis. 2020 Jul;26(7):1583-1591
pubmed: 32275497
J Aerosol Sci. 2009 Feb;40(2):122-133
pubmed: 32287373
Am J Respir Crit Care Med. 2016 Aug 1;194(3):308-16
pubmed: 26890617
Chest. 1998 Jan;113(1):234-7
pubmed: 9440596
Nat Commun. 2021 Jan 11;12(1):267
pubmed: 33431879
Int J Infect Dis. 2020 Nov;100:476-482
pubmed: 32949774
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Nature. 2005 Nov 17;438(7066):293-5
pubmed: 16292292
Sci Rep. 2020 Jul 29;10(1):12732
pubmed: 32728118
Sci Total Environ. 2020 Jul 10;725:138401
pubmed: 32283308
J Appl Physiol. 1971 Dec;31(6):870-2
pubmed: 5123666
Clin Infect Dis. 2020 Jul 28;71(15):769-777
pubmed: 32176772
Sci Rep. 2019 Feb 20;9(1):2348
pubmed: 30787335
J Occup Environ Hyg. 2005 Mar;2(3):143-54
pubmed: 15764538
Nat Commun. 2020 Jul 8;11(1):3496
pubmed: 32641684
Lancet Infect Dis. 2020 Apr;20(4):411-412
pubmed: 32105638
Nature. 2020 Jun;582(7813):557-560
pubmed: 32340022
Environ Int. 2020 Aug;141:105794
pubmed: 32416374
BMC Infect Dis. 2019 Jan 31;19(1):101
pubmed: 30704406
Nature. 2005 Nov 17;438(7066):355-9
pubmed: 16292310
Int Forum Allergy Rhinol. 2020 Aug;10(8):968-969
pubmed: 32323923
J Pediatric Infect Dis Soc. 2020 Sep 17;9(4):413-415
pubmed: 32706376
J Infect. 2008 Nov;57(5):361-73
pubmed: 18848358
Risk Anal. 2020 May;40(5):902-907
pubmed: 32356927
J Hyg (Lond). 1946 Sep;44(6):471-9
pubmed: 20475760
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
N Engl J Med. 2004 Apr 22;350(17):1731-9
pubmed: 15102999
Ir J Med Sci. 2020 Nov;189(4):1143-1144
pubmed: 32212099
J Aerosol Med Pulm Drug Deliv. 2011 Jun;24(3):137-47
pubmed: 21361786
Am Rev Respir Dis. 1968 Aug;98(2):297-300
pubmed: 5667756
Environ Int. 2020 Jun;139:105730
pubmed: 32294574
Bacteriol Rev. 1966 Sep;30(3):576-88
pubmed: 5917337
Nat Med. 2020 May;26(5):676-680
pubmed: 32371934
PLoS Pathog. 2013 Mar;9(3):e1003205
pubmed: 23505369
Int J Environ Res Public Health. 2020 Apr 23;17(8):
pubmed: 32340347
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):606-610
pubmed: 32407303
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1081-1086
pubmed: 29348203
J Clin Virol. 2020 Aug;129:104439
pubmed: 32674034
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):11875-11877
pubmed: 32404416
Edinb Med J. 1945 Nov;52:385-401
pubmed: 21009905
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Infect Immun. 2005 Apr;73(4):2469-77
pubmed: 15784593
J Occup Environ Hyg. 2012;9(7):443-9
pubmed: 22651099
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
J Infect. 2011 Jan;62(1):1-13
pubmed: 21094184

Auteurs

Jack Schijven (J)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Department of Earth Sciences, Utrecht University, Utrecht, Netherlands.

Lucie C Vermeulen (LC)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Arno Swart (A)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Adam Meijer (A)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Erwin Duizer (E)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Ana Maria de Roda Husman (AM)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Institute for Risk Assessment Sciences, Utrecht University, Utrecht, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Préparations pharmaceutiques › Colloïdes › Aérosols › Quantitative Microbial Risk Assessment for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Microbiologie de l'environnement › Microbiologie de l'air › Quantitative Microbial Risk Assessment for...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Quantitative Microbial Risk Assessment for...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Signes et symptômes respiratoires › Toux › Quantitative Microbial Risk Assessment for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Transmission de maladie infectieuse › Quantitative Microbial Risk Assessment for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Quantitative Microbial Risk Assessment for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Quantitative Microbial Risk Assessment for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Quantitative Microbial Risk Assessment for...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Quantitative Microbial Risk Assessment for...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiologiques respiratoires › Phonation › Chant › Quantitative Microbial Risk Assessment for...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiologiques respiratoires › Éternuement › Quantitative Microbial Risk Assessment for...